Tslynk67
Well-Known Member
I see. Lycanthrope wants to sell livers of short sellers to ruin them twice.
I'm partial to a bit of liver, actually tend to eat it raw. Make of that, what you will...
You can install our site as a web app on your iOS device by utilizing the Add to Home Screen feature in Safari. Please see this thread for more details on this.
Note: This feature may not be available in some browsers.
I see. Lycanthrope wants to sell livers of short sellers to ruin them twice.
With onions?
Second that. More de-liver!Mod: Enough with the liver, please. --ggr
$295 is my new hated number
Lots of research out today - Barclays, MS, Bernstein
I think there is some truth to that and it's borne out today. MS is the only one that gets significant revenue from Tesla and is the only one with a price target over $300 - $376, Bernstein & Barclays are $265 and $210 respectively.often with analyst reports I’ve found you get what’s been paid for (this is by no means limited to analyst reports on Tesla).
I think there is some truth to that and it's borne out today. MS is the only one that gets significant revenue from Tesla and is the only one with a price target over $300 - $376, Bernstein & Barclays are $265 and $210 respectively.
280?Looking forward to the confirmed and sustainable 6k/week that will allow us to recover back to 280 two weeks from now.
I'm venting frustration
I hope we hold 290 today
I freed up some cash and I am trying to figure out if I should hold until the next quarterly earnings come in (which shorts will no doubt have a field trip with) and wait for better buying opportunity then, or just buy now and get it over with. Decisions, decisions.....
I freed up some cash and I am trying to figure out if I should hold until the next quarterly earnings come in (which shorts will no doubt have a field trip with) and wait for better buying opportunity then, or just buy now and get it over with. Decisions, decisions.....